GlaxoSmithKline's Push for an Ebola Vaccine

The video discusses GlaxoSmithKline's (GSK) efforts in developing an Ebola vaccine. In 2013, GSK acquired a company with an Ebola vaccine candidate. The World Health Organization (WHO) requested GSK to advance the vaccine to phase one trials amid the Ebola crisis. The trials are conducted in the US, UK, and West Africa, with results expected by the end of the year. The video highlights the lengthy vaccine development process and the collaboration between government, private industry, and charitable organizations to expedite trials. It also addresses the Ebola outbreak's impact and containment efforts in the US and West Africa.

What factors are contributing to the acceleration of the vaccine trial process?

What was the reaction of the health organization to the Ebola diagnosis in Dallas?